A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma
- Type
- Retraction
- Notice date
- 2/22/2024 0:00
- Journal
- Frontiers in Oncology
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fonc.2024.1383375
- Original paper DOI
- 10.3389/fonc.2023.1136366
Reasons
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Third Party Involvement
- Concerns/Issues about Peer Review
- Compromised Peer Review
- Investigation by Journal/Publisher